Patents Represented by Attorney, Agent or Law Firm Ivor E. Elrifi
  • Patent number: 6713253
    Abstract: A method and kit for predicting increased risk of sight-threatening diabetic retinopathy which includes isolating genomic DNA from a sample from a diabetic patient. The genetic polymorphism pattern for the genes IL-1A, IL-1B and IL-1RN is then identified in the DNA. The identified pattern is compared with control patterns of known polymorphisms, and patients expressing a genetic polymorphism pattern associated with increased risk of sight-threatening diabetic retinopathy are identified.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: March 30, 2004
    Assignee: Interleukin Genetics, Inc.
    Inventors: Gordon W. Duff, Patrick R. S. Richardson, Ian G. Rennie